Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice.
Seedorf, K., Weber, C., Vinson, C., Berger, S., Vuillard, L.M., Kiss, A., Creusot, S., Broux, O., Geant, A., Ilic, C., Lemaitre, K., Richard, J., Hammoutene, A., Mahieux, J., Martiny, V., Durand, D., Melchiore, F., Nyerges, M., Paradis, V., Provost, N., Duvivier, V., Delerive, P.(2023) JHEP Rep 5: 100651-100651
- PubMed: 36866391 
- DOI: https://doi.org/10.1016/j.jhepr.2022.100651
- Primary Citation of Related Structures:  
8A46 - PubMed Abstract: 
Oxidative stress is recognized as a major driver of non-alcoholic steatohepatitis (NASH) progression. The transcription factor NRF2 and its negative regulator KEAP1 are master regulators of redox, metabolic and protein homeostasis, as well as detoxification, and thus appear to be attractive targets for the treatment of NASH.
Organizational Affiliation: 
Cardiovascular and Metabolic Diseases Research, Institut de Recherches Servier, Suresnes, France.